Evidence map›Paper›PMID 31888545›Full record

ArticleBMC cancer2019

Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM).

Yuejiao Huang, Xianting Huang, Chun Cheng, Xiaohong Xu, Hong Liu, Xiaojing Yang, Li Yao, Zongmei Ding, Jie Tang, Song He and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Autism risk geneFrontiers in cellular neuroscience · 2024
    Article
  6. Article
  7. CAM-DR: Mechanisms, Roles and Clinical Application in Tumors.Frontiers in cell and developmental biology · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yuejiao HuangDepartment of Oncology, Nantong University Cancer Hospital, Nantong, Jiangsu, 226001, People's Republic of China.
Xianting HuangDepartment of Oncology center, Jiangsu Jiangyin People's Hospital, Jiangyin, Jiangsu, 214400, People's Republic of China.
Chun ChengDepartment of Pathogenic Biology, School of Medicine, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Xiaohong XuDepartment of Oncology, Nantong University Cancer Hospital, Nantong, Jiangsu, 226001, People's Republic of China.
Hong LiuDepartment of Hematology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Xiaojing YangDepartment of Pathogenic Biology, School of Medicine, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Li YaoDepartment of Immunology, Medical College of Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China.
Zongmei DingDepartment of Pathogenic Biology, School of Medicine, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Jie TangDepartment of Pathogenic Biology, School of Medicine, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Song HeDepartment of Pathology, Nantong University Cancer Hospital, Nantong, Jiangsu, 226001, People's Republic of China. hesong2009@126.com.
Yuchan WangDepartment of Pathogenic Biology, School of Medicine, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China. ychan.wang@163.com.
Nantong University · CNJiangnan University · CNJiangyin People's Hospital · CN

Funding

Major Research of Natural Science Foundation for Colleges and Universities in Jiangsu Province 16KJ320004National Funds for Distinguished Young Scientists of Nantong WQ2016057National Natural Science Foundation of China 81600158National Natural Science Foundation of China 81670196Natural Science Foundation of Jiangsu Province BK20160060Six Talent Peaks Project in Jiangsu Province 2015-SWYY-021
6 · The paper itself

Abstract

backgroundCell adhesion-mediated drug resistance (CAM-DR) is a major clinical problem that prevents successful treatment of multiple myeloma (MM). In particular, the expression levels of integrin β1 and its sub-cellular distribution (internalization and trafficking) are strongly associated with CAM-DR development.

methodsDevelopment of an adhesion model of established MM cell lines and detection of Numbl and Integrinβ1 expression by Western Blot analysis. The interaction between Numbl and Integrinβ1 was assessed by a co-immunoprecipitation (CO-IP) method. Calcein AM assay was performed to investigate the levels of cell adhesion. Finally, the extent of CAM-DR in myeloma cells was measured using cell viability assay and flow cytometry analysis.

resultsOur preliminary date suggest that Numbl is differentially expressed in a cell adhesion model of MM cell lines. In addition to binding to the phosphotyrosine-binding (PTB) domain, the carboxyl terminal of Numbl can also interact with integrin β1 to regulate the cell cycle by activating the pro-survival PI3K/AKT signaling pathway. This study intends to verify and elucidate the interaction between Numbl and integrin β1 and its functional outcome on CAM-DR. We have designed and developed a CAM-DR model using MM cells coated with either fibronectin or bone marrow stromal cells. We assessed whether Numbl influences cell-cycle progression and whether it, in turn, contributes to activation of PI3K/AKT signal pathway through the adjustment of its carboxyl end. Finally, we showed that the interaction of Numbl with integrin β1 promotes the formation of CAM-DR in MM cells.

conclusionsOur findings elucidated the specific molecular mechanisms of CAM-DR induction and confirmed that Numbl is crucial for the development of CAM-DR in MM cells.

Indexed as

Cell AdhesionCell CycleCell LineCell SurvivalDexamethasoneDoxorubicinDrug Resistance, NeoplasmGene ExpressionHumansIntegrin beta1Intracellular Signaling Peptides and ProteinsMitoxantroneMultiple MyelomaPhosphatidylinositol 3-KinasesProtein BindingSignal TransductionDexamethasoneDoxorubicinIntegrin beta1Intracellular Signaling Peptides and ProteinsMitoxantroneNUMBL protein, humanPhosphatidylinositol 3-KinasesIntegrin β1, CAM-DRMMNumbl

Identifiers

PMID31888545
PMCPMC6937660
OpenAlexW2998128524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.